CAMP HILL, Pa., 2016-Mar-05 — /EPR Retail News/ — Rite Aid Corporation (NYSE: RAD) today announced sales results of its retail pharmacy segment for February.
Monthly Sales
For the five weeks ended Feb. 27, 2016, same store sales decreased 0.8 percent over the prior-year period. February front-end same store sales decreased 0.5 percent. Pharmacy same store sales, which included an approximate 269 basis points negative impact from new generic introductions, decreased 0.9 percent. Prescription count at comparable stores increased 1.4 percent over the prior-year period.
Total drugstore sales for the five-week period increased 0.1 percent with isalessales of $2.562 billion compared to $2.559 billion for the same period last year. Prescription sales accounted for 69.4 percent of drugstore sales, and third party prescription sales represented 98.0 percent of pharmacy sales.
Quarterly Sales
Same store sales for the 13-week period ended Feb. 27, 2016 decreased 0.6 percent over the prior-year period. Front-end same store sales decreased 0.4 percent while pharmacy same store sales decreased 0.8 percent. Prescription count at comparable stores increased 0.1 percent over the prior-year period.
Total drugstore sales for the 13 weeks ended Feb. 27, 2016 decreased 0.3 percent with sales of $6.775 billion compared to $6.796 billion for the same period last year. Prescription sales represented 68.1 percent of total drugstore sales, and third party prescription sales represented 97.9 percent of pharmacy sales.
Year-to-Date
Same store sales for the 52-week period ended Feb. 27, 2016 increased 1.3 percent over the prior-year period. Front-end same store sales increased 0.2 percent while pharmacy same store sales increased 1.8 percent. Prescription count at comparable stores increased 0.5 percent over the prior-year period.
Total drugstore sales for the 52 weeks ended Feb. 27, 2016 increased 1.3 percent with sales of $26.681 billion compared to $26.349 billion for the same period last year. Prescription sales represented 69.1 percent of total drugstore sales, and third party prescription sales represented 97.8 percent of pharmacy sales.
Going forward, Rite Aid will no longer report sales and comparable store sales results on a monthly basis. Rite Aid will continue to provide this information on a quarterly basis as part of its quarterly reporting.
Rite Aid is one of the nation’s largest drugstore chains. On Feb. 27, 2016, the company operated 4,561 stores compared to 4,570 stores in the like period a year ago. Information about Rite Aid, including corporate background and press releases, is available through the company’s website at http://www.riteaid.com. Note that all sales data in this release is preliminary, unaudited and subject to revision.
Statements in this release that are not historical are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties that are described in Item 1A (Risk Factors) of our most recent Annual Report on Form 10-K and in other documents that we file or furnish with the Securities and Exchange Commission, which you are encouraged to read. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Rite Aid expressly disclaims any current intention to update publicly any forward-looking statement after the distribution of this release, whether as a result of new information, future events, changes in assumptions or otherwise.
###
Contact:
Investors: Matt Schroeder 717-214-8867 or investor@riteaid.com
Media: Susan Henderson 717-730-7766